The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Addressing biases in lung cancer studies and clinical trials
Sitapriya Moorthi, PhD, Fred Hutchinson Cancer Center, Seattle, WA, highlights disparities in lung cancer research in terms of race, gender, sex, and age. Studies have highlighted potential genetic differences in these groups, especially considering that more non-smokers with lung cancer are women. More inclusive studies in this area will reflect to more accurate results that reflect the real-world. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
